|
Closing the Gap
between Urban and Rural HPV Vaccination Rates
Tuesday,
September 18, 2018
12:00 pm - 1:00 pm Eastern/ 9:00 am - 10:00 am Pacific
In addition to a yearly flu vaccine, CDC recommends three
vaccines for adolescents to protect against serious diseases: meningococcal
conjugate vaccine, HPV vaccine, and Tdap vaccine. Nationally, HPV vaccination
rates have been increasing in recent years, and rates of Tdap and meningococcal
conjugate vaccine have been high for several years. However, recent data have
shown that fewer adolescents in rural areas are getting the HPV and
meningococcal conjugate vaccines compared to adolescents in urban areas.
This webinar will highlight the latest data on adolescent
vaccination coverage nationally and among rural areas, examine various factors
that may influence uptake of the HPV vaccine in rural communities, and present
evidence-based strategies to help address this disparity.
Join the Rural Health
Information Hub on Tuesday, September 18 at 12:00 PM ET for a webinar titled,
“Closing the Gap between Urban and Rural HPV Vaccination Rates.”
Featured
Speakers:
-
Tanja
Walker, MPH, Epidemiologist, CDC’s National Center for Immunization and
Respiratory Diseases will
discuss the 2017 National Immunization Survey-Teen results recently
published in CDC’s Morbidity and Mortality Weekly Report. This report
provides the latest coverage estimates for the vaccines routinely
recommended for adolescents at the national, state, and selected local
levels, and some U.S. territories.
-
Robin C. Vanderpool, DrPH, Associate Professor,
Department of Health, Behavior & Society, University of Kentucky (UK)
College of Public Health will
provide an overview of the burden of HPV-associated cancers in rural
communities, HPV vaccine knowledge/awareness differences between
rural/urban populations, and the unique challenges and opportunities
associated with rural HPV vaccination.
-
Electra
D. Paskett, PhD, Marion N. Rowley Professor of Cancer Research, The Ohio
State University will highlight
the development of an HPV vaccination intervention and its implementation
in a full-randomized control trial then as a pilot dissemination study in
Ohio Appalachia.
|
